E. Turk

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.

Sylvia Janetzki, Guido Ferrari, D. Birx, 2002, Journal of immunological methods.

Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection

Jerome H. Kim, J. Lifson, J. Ananworanich, 2018, Nature Medicine.

Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial

Raphael Gottardo, S. Gnanakaran, Hongmei Gao, 2013, PloS one.

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.

Hongmei Gao, Marcella Sarzotti-Kelsoe, Daniel A Ozaki, 2014, Journal of immunological methods.

Isolation of human monoclonal antibodies from peripheral blood B cells

J. Mascola, S. Migueles, M. Connors, 2013, Nature Protocols.

Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities

J. Ananworanich, M. Robb, L. Trautmann, 2018, The Journal of infectious diseases.

High throughput HIV-1 microneutralization assay

J. Mascola, M. Connors, R. Bailer, 2013 .

Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells

Hongjun Bai, D. Douek, J. Ananworanich, 2022, EBioMedicine.

Viral Blips After Treatment Initiation During Acute Human Immunodeficiency Virus Infection

J. Ananworanich, M. Robb, M. de Souza, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.

J. Mascola, D. Montefiori, R. Bailer, 2014, Journal of immunological methods.